SciELO - Scientific Electronic Library Online

vol.2 issue1Artificial Hepatic Support System: When, to whom and why?Hemophagocytic syndrome: a rare complication in patients with human immunodeficiency virus (HIV) infection author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



Related links


Revista Uruguaya de Medicina Interna

Print version ISSN 2393-6797On-line version ISSN 2393-6797


SILVEIRA, Gonzalo et al. Evaluation of the prescription of pharmacological thrombo-prophylaxis and assessment of the impact generated by different strategies to improve its indication. Rev. Urug. Med. Int. [online]. 2017, vol.2, n.1, pp.21-24. ISSN 2393-6797.


Venous thromboembolic disease (VTE) is the leading cause of preventable death in hospitalized patients. The Padua score is currently validated to detect patients with medical pathology with a high risk of VTE.


to analyze the prescription of pharmacological thromboprophylaxis in patients hospitalized for medical pathology and to analyze the impact of different strategies to stimulate the prescription of thromboprophylaxis.


A cross-sectional study was carried out of all patients admitted to moderate medical care in December 2014 applying the Padova score. After several educational interventions, a second cross-sectional study was carried out one year later using the same tool.


48/67 patients analyzed in the first cut had a high risk of thrombosis, only 29 had an indication of pharmacological thromboprophylaxis. 32/52 patients analyzed in the second section had an indication, being prescribed in 26 of them (p: 0.0062)


inclusion of the Padua score in the medical records, implementation of guidelines review, promotion of Thromboprophylaxis and ETEV awareness in the medical staff significantly increased its prescription.

Keywords : venous thromboembolic disease; pharmacological thromboprophylaxis; prevention.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )